Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine

SAN DIEGO, April 8, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has been issued a Notice of Allowance for a…

Medical Marijuana, Inc. Subsidiary Kannaway ® Promotes Stephen Jones to President

Medical Marijuana, Inc. Subsidiary Kannaway ® Promotes Stephen Jones to President

SAN DIEGO, April 14, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has promoted the Company’s Chief Marketing Officer Stephen Jones to President.Stephen Jones, President of Kannaway®”Over the past…

Medical Cannabis, Inc. Portfolio Investment Firm Kannalife, Inc. Gets Patent in Australia for Its Unique Monotherapeutic Compounds to Treat CNS and PNS Disorders

Medical Cannabis, Inc. Portfolio Investment Firm Kannalife, Inc. Gets Patent in Australia for Its Unique Monotherapeutic Compounds to Treat CNS and PNS Disorders

SAN DIEGO, March 19, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) has been issued Australian Patent AU2015204609B2 (the “Patent”) specific to…

The Very Best CBD For Anxiety

The Very Best CBD For Anxiety

Forget the meditation cushions and the mindfulness apps — if the coronavirus has got you feeling anxious these days, it may be time to consider adding some CBD to your self-care routine. As cases of COVID-19 continue to spike across the country, so have cases of anxiety. New data from the American Psychiatric Association last…

Weekly Link Love– Edition 73

Weekly Link Love– Edition 73

Research of the Week Malaria drug shows promise against coronavirus. Coronavirus shows different levels of stability on different surfaces. Coronavirus patients may have lower cholesterol. No word on causation—could very well be that infection decreases cholesterol. A study in Thailand finds that hospitalized coronavirus patients tend to have low potassium levels. New Primal Blueprint Podcasts…

HempMeds ®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Cast Line with Two New Flavors

HempMeds ®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Cast Line with Two New Flavors

SAN DIEGO, March 31, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has expanded its popular line of naturally flavored Dixie Botanicals® Dew Drops Cannabidiol (CBD) Oil Tinctures to include strawberry…

Medical Marijuana, Inc. Subsidiary Kannaway® Launches New Hemp + Calm CBD Oral Applicator in Europe

SAN DIEGO, March 10, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a new cannabidiol (CBD) product, its Hemp + Calm Oral Applicator, in Europe. This product is…